Cargando…
厄洛替尼治疗34例肺鳞癌患者的疗效观察
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhinitors (EGFR-TKIs) inhibit tumor growth by affecting signal transduction, and are well tolerated. The aims of this study was to observe the effect of erlotinib in patients with squamous cell lung cancer. METHODS: The 34 p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973416/ https://www.ncbi.nlm.nih.gov/pubmed/27760598 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.08 |
Ejemplares similares
-
高龄肺鳞癌患者的临床病理特征
Publicado: (2016) -
晚期肺鳞癌的治疗
Publicado: (2016) -
肺鳞癌的免疫治疗进展
Publicado: (2016) -
72例肺腺鳞癌临床病理特点和预后因素分析
Publicado: (2016) -
晚期肺鳞癌患者肿瘤标志物测定的临床分析
Publicado: (2016)